07/13/Page 14 of7. 8.9. ten.11.12.13. 14.15.16.17. 18.19. 20.21.22.23.24. 25.26.27. 28.29.Smith RA, Hartley RC, Murphy MP: Mitochondria-targeted tiny molecule therapeutics and probes. Antioxid Redox Signal 2011, 15:3021038. Millard M, Pathania D, Shabaik Y, Taheri L, Deng J, Neamati N: Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PLoS One 2010, 5:e13131. doi:ten.1371/journal.pone.0013131. Ju J, Picinich SC, Yang Z, Zhao Y, Suh N, Kong AN, Yang CS: Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010, 31:53342. Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Krishnan BB: {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine remedy by modulating the inflammatory microenvironment. Cancer Res 2010, 70:8695705. Li GX, Lee MJ, Liu AB, Yang Z, Lin Y, Shih WJ, Yang CS: delta-tocopherol is a lot more active than alpha – or gamma -tocopherol in inhibiting lung tumorigenesis in vivo. Cancer Prev Res (Phila) 2011, 4:40413. Shah SJ, Sylvester PW: Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity.MB-07811 Exp Biol Med (Maywood) 2005, 230:23541.Dipyridamole Azzi A, Ricciarelli R, Zingg JM: Non-antioxidant molecular functions of alpha-tocopherol (vitamin E).PMID:24761411 FEBS Lett 2002, 519:80. Neuzil J, Tomasetti M, Zhao Y, Dong LF, Birringer M, Wang XF, Low P, Wu K, Salvatore BA, Ralph SJ: Vitamin E analogs, a novel group of “mitocans,” as anticancer agents: the significance of becoming redox-silent. Mol Pharmacol 2007, 71:1185199. Dong LF, Freeman R, Liu J, Zobalova R, Marin-Hernandez A, Stantic M, Rohlena J, Valis K, Rodriguez-Enriquez S, Butcher B, Goodwin J, Brunk UT, Witting PK, Moreno-Sanchez R, Scheffler IE, Ralph SJ, Neuzil J: Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate needs respiratory complicated II. Clin Cancer Res 2009, 15:1593600. Dong LF, Jameson VJ, Tilly D, Cerny J, Mahdavian E, Marin-Hernandez A, Hernandez-Esquivel L, Rodriguez-Enriquez S, Stursa J, Witting PK, Stantic B, Rohlena J, Truksa J, Kluckova K, Dyason JC, Ledvina M, Salvatore BA, Moreno-S chez R, Coster MJ, Ralph SJ, Smith RA, Neuzil J: Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity through mitochondrial complicated II. J Biol Chem 2011, 286:3717728. Wang F, Ogasawara MA, Huang P: Smaller mitochondria-targeting molecules as anti-cancer agents. Mol Aspects Med 2010, 31:752. Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, Keszler A, Joseph J, Kalyanaraman B: Supplementation of endothelial cells with mitochondriatargeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative harm, and apoptosis. J Biol Chem 2004, 279:375757587. Holliday DL, Speirs V: Picking out the proper cell line for breast cancer study. Breast Cancer Res 2011, 13:215. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic system mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:53749. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:51824. Wendt MK, Cooper AN, Dwinell MB: Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cells. Oncogene 2008, 27:1461471. Fischer.